54767414SMM3001 (AQUILA) (FL)

54767414SMM3001 (AQUILA) (FL)

A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects With High-Risk Smoldering Multiple Myeloma (SMM) (AQUILA)


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link